{
  "thread": {
    "uuid": "e7d92c840796ddcd45ef3cc8979db5dd18379b06",
    "url": "https://finance.sina.com.cn/money/fund/aiassistant/etfwp/2025-06-19/doc-infaqrft3927990.shtml",
    "site_full": "finance.sina.com.cn",
    "site": "sina.com.cn",
    "site_section": "http://finance.sina.com.cn/fund/",
    "site_categories": [
      "tech",
      "top_news_hk",
      "top_news_sg",
      "top_news_tw",
      "top_news"
    ],
    "section_title": "基金首页_新浪财经_新浪网",
    "site_title": null,
    "title": "创新药ETF易方达（516080）跌1.31%，半日成交额792.33万元|易方达_新浪财经_新浪网",
    "title_full": "创新药ETF易方达（516080）跌1.31%，半日成交额792.33万元|易方达_新浪财经_新浪网",
    "published": "2025-06-19T06:32:00.000+03:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "CN",
    "main_image": "",
    "performance_score": 0,
    "domain_rank": 236,
    "domain_rank_updated": "2025-06-03T00:00:00.000+03:00",
    "licensing_agency": [],
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "e7d92c840796ddcd45ef3cc8979db5dd18379b06",
  "url": "https://finance.sina.com.cn/money/fund/aiassistant/etfwp/2025-06-19/doc-infaqrft3927990.shtml",
  "ord_in_thread": 0,
  "author": "小浪财讯",
  "published": "2025-06-19T06:32:00.000+03:00",
  "title": "创新药ETF易方达（516080）跌1.31%，半日成交额792.33万元|易方达_新浪财经_新浪网",
  "text": "6月19日，截止午间收盘，创新药ETF易方达（516080）跌1.31%，报0.605元，成交额792.33万元。创新药ETF易方达（516080）重仓股方面， 药明康德 截止午盘跌1.02%， 恒瑞医药 跌0.66%， 科伦药业 跌1.28%， 华东医药 涨0.39%， 复星医药 跌1.08%， 长春高新 跌2.06%， 智飞生物 跌1.41%， 康龙化成 跌1.97%， 百济神州 跌1.21%， 泰格医药 跌1.21%。\n创新药ETF易方达（516080）业绩比较基准为中证创新药产业指数收益率，管理人为易方达基金管理有限公司，基金经理为伍臣东，成立（2021-02-03）以来回报为-38.66%，近一个月回报为6.59%。\n风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建议。\nMACD金叉信号形成，这些股涨势不错！",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "chinese",
  "sentiment": "negative",
  "categories": [
    "Economy, Business and Finance",
    "Science and Technology",
    "Social Issue"
  ],
  "topics": [
    "Economy, Business and Finance->investment and opinion pieces",
    "Economy, Business and Finance->business reporting and performance",
    "Economy, Business and Finance->financial service",
    "Science and Technology->biotechnology",
    "Science and Technology->biomedical science",
    "Social Issue->demographics",
    "Social Issue->social condition",
    "Social Issue->population and census"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": null,
  "webz_reporter": false,
  "external_links": [
    "https://finance.sina.cn/app/sfa_macd.shtml?source=pccj",
    "https://www.finance.sina.cn/app/sfa_macd.shtml?source=pccj",
    "https://finance.sina.cn/app/sfa_macd.shtml"
  ],
  "entities": {
    "persons": [],
    "locations": [],
    "organizations": []
  },
  "syndication": {
    "syndicated": null,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": {
    "categories": [],
    "top_news": [
      "top_news_hk",
      "top_news_sg",
      "top_news_tw",
      "top_news"
    ],
    "bias": null
  },
  "rating": null,
  "crawled": "2025-06-19T07:39:27.980+03:00",
  "updated": "2025-06-20T05:09:51.000+00:00"
}